Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pathobiology. 2004;71(5):281-6.

Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.

Author information

  • 1Division of Operating Room, Faculty of Medicine, Tottori University, Yonago, Japan. masaike@grape.med.tottori-u.ac.jp

Abstract

OBJECTIVES:

c-myc is a transcription factor that regulates cell proliferation, differentiation, and apoptosis. However, little is known about the clinical importance of c-myc mRNA expression in a primary hepatocellular carcinoma (HCC). In this study, we investigated whether a correlation existed between the level of c-myc mRNA expression and the occurrence of apoptosis or proliferative activity in an HCC.

METHODS:

The levels of c-myc mRNA expression were quantified by real-time reverse transcriptase polymerase chain reaction (RT-PCR) and compared with immunohistochemical detection of the occurrence of spontaneous apoptosis and proliferative activity of cancer cells in 59 surgically resected HCCs.

RESULTS:

The mean level of c-myc mRNA expression in 59 HCCs (1.19) was significantly suppressed compared with that in 59 noncancerous liver tissues (1.44, p<0.0001). The level of c-myc mRNA expression was not correlated with tumor differentiation, tumor progression, proliferative activity of cancer cells, or patient survival. However, there was a significant positive correlation between the levels of c-myc mRNA expression and the occurrence of apoptosis in 59 HCCs (p<0.001).

CONCLUSIONS:

Inhibition of c-myc mRNA expression may obstruct the induction of apoptosis of HCC cells and lead to uncontrolled cell growth.

PMID:
15459488
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk